Viatris Inc

NASDAQ:VTRS 4:00:00 PM EDT

9.40

-0.25 (-2.59%)

6:55:26 PM EDT: $9.43 +0.03 (+0.32%)

Products

Biocon Biologics Gets Deferred FDA Action On License Application For Avastin Biosimilar

Published: 12/25/2020 08:31 GMT

Viatris Inc (VTRS) - FDA Tells Biocon Biologics of Deferred Action on License Application for Myl-1402o, Proposed Biosimilar to Avastin.
FDA Says Inspection of Plant Required to Complete Application.
FDA Unable to Conduct Inspection Currently Due to Covid-19 Restrictions.
FDA Made No Other Observations Related to Application.